A Harłozińska
- Molecular Biology
- Oncology
- Reproductive Medicine top 5%
- Radiology, Nuclear Medicine and Imaging
- Surgery
- Co-authors
- P SedlaczekJulia BarR. EinarssonRonald RichterA. van DalenM GabryśJanina MarkowskaIrena Frydecka
- Topics
- Ovarian cancer diagnosis and treatment (17 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)Radiopharmaceutical Chemistry and Applications (7 papers)
- Partner nations
- PolandUnited KingdomGermany
In The Last Decade
A Harłozińska
49 papers receiving 556 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 234
- Oncology 219
- Reproductive Medicine 144
- Radiology, Nuclear Medicine and Imaging 103
- Surgery 83
Countries citing papers authored by A Harłozińska
This map shows the geographic impact of A Harłozińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Harłozińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Harłozińska more than expected).
Fields of papers citing papers by A Harłozińska
This network shows the impact of papers produced by A Harłozińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Harłozińska. The network helps show where A Harłozińska may publish in the future.
Co-authorship network of co-authors of A Harłozińska
This figure shows the co-authorship network connecting the top 25 collaborators of A Harłozińska. A scholar is included among the top collaborators of A Harłozińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Harłozińska. A Harłozińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. | 35 |
| 3 | 4 | |
| 4 | Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias. | 15 |
| 5 | 45 | |
| 6 | Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1). | 8 |
| 7 | Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. | 46 |
| 8 | Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement. | 16 |
| 9 | p53, c-erbB-2 and p21ras expression in tumor effusion cells of patients with histopathologically different ovarian neoplasms. | 6 |
| 10 | 8 | |
| 11 | Relationship between c-erbB-2 oncoprotein, epidermal growth factor receptor, and estrogen receptor expression in patients with ductal breast carcinoma. Association with tumor phenotypes. | 17 |
| 12 | 17 | |
| 13 | In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes. | 2 |
| 14 | Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. | 5 |
| 15 | Density distribution, cytomorphologic features and immunologic characteristics of ovarian and endometrial clear cell carcinomas. | 2 |
| 16 | 14 | |
| 17 | Antigenic heterogeneity of human lung cancers. | 7 |
| 18 | Localization of carcinoembryonic antigen in mesenteric lymph nodes of patients with gastrointestinal cancer. | 1 |
| 19 | Reagents for radioimmunological determination of carcinoembryonic antigen (CEA). | 1 |
| 20 | Antitumor immunity in patients with carcinoma of the large intestine. | 0 |
About A Harłozińska
A Harłozińska is a scholar working on Reproductive Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 55 papers that have together received 587 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (17 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). The work is most often cited by research in Reproductive Medicine (144 citations), Oncology (219 citations) and Cancer Research (76 citations). A Harłozińska has collaborated with scholars based in Poland, United Kingdom and Germany. Frequent co-authors include P Sedlaczek, Julia Bar, R. Einarsson, Ronald Richter, A. van Dalen, M Gabryś, Janina Markowska, Irena Frydecka, Marek Bębenek and Mathias Montenarh. Their work appears in journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.